Diagnostic potential of genomic blood biomarkers of pulmonary fibrosis in a prospective cohort

Daniel He, Casey P. Shannon, Jeremy A. Hirota, Kjetil Ask, Christopher J. Ryerson, Scott J. Tebbutt · 2024

Read Diagnostic potential of genomic blood biomarkers of pulmonary fibrosis in a prospective cohort by Daniel He, Casey P. Shannon, Jeremy A. Hirota, Kjetil Ask, Christopher J. Ryerson, Scott J. Tebbutt (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11614250.txt.

Description

Daniel He and co-authors hunt blood marks for lung scarring types in a 2024 study. Scarred lung diseases look alike yet need unlike care. Telling one type from its kin can be hard with scans and tests alone.

The team read one hundred sixty six genes in whole blood from a tracked group. One gene split two major scarring types cleanly. Two more genes marked the most common type against the rest. Lung tissue checks backed the blood finds. A blood gene test could one day sort scarred lungs with less need for lung samples.

Catalog record

CREATORDaniel He, Casey P. Shannon, Jeremy A. Hirota, Kjetil Ask, Christopher J. Ryerson, Scott J. Tebbutt
YEAR2024
COLLECTIONPAPERS
FORMATTXT
FILE SIZE17 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11614250

Browse the full library · About the Tower of Babel